squaric acid diethyl ester: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 123228 |
| SCHEMBL ID | 94221 |
| MeSH ID | M0062529 |
| Synonym |
|---|
| 3-cyclobutene-1,2-dione, 3,4-diethoxy- |
| 3,4-diethoxy-3-cyclobutene-1,2-dione |
| squaric acid diethyl ester |
| diethoxycyclobutenedione |
| 3,4-diethoxy-3-cyclobutene-1,2-dione, 98% |
| 5231-87-8 |
| diethyl squarate , |
| D3253 |
| 3,4-diethoxycyclobut-3-ene-1,2-dione |
| dfsflzclkyzyrd-uhfffaoysa- |
| inchi=1/c8h10o4/c1-3-11-7-5(9)6(10)8(7)12-4-2/h3-4h2,1-2h3 |
| 3,4-diethoxycyclobut-3-ene-1,2-dione;diethyl squarate |
| A829027 |
| 3,4-diethoxy-cyclobut-3-ene-1,2-dione |
| diethoxycyclobut-3-ene-1,2-dione |
| BP-13098 |
| FT-0600794 |
| PS-4470 |
| AM20100287 |
| AKOS015905438 |
| SCHEMBL94221 |
| SY013529 |
| mfcd00001333 |
| 3.4-diethoxy-3-cyclobutene-1,2-dione |
| 3,4,-diethoxy-3-cyclobutene-1,2-dione |
| 3,4-diethoxy-3 cyclobutene-1,2-dione |
| 3,4-diethoxy-3-cyclobuten-1,2-dion |
| 3,4-diethyoxy-3-cyclobutene-1,2-dione |
| 3,4-diethoxy-3-cyclobuten-1,2-dione |
| 1,2-diethoxycyclobutene-3,4-dione |
| 1,2-diethoxycyclobutenedione |
| AC-22926 |
| J-511148 |
| DTXSID30200334 |
| CS-W004755 |
| EN300-215540 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.73) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 1 (8.33%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 1 (8.33%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 10 (83.33%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||